Address book
Contacts
NICOLA REALDON
Position
DOCENTE
Address
Telephone
Notices
Office hours
Tuesday from 16:00 to 17:00
at Dipartimento di Scienze del Farmaco
Si raccomanda di inoltrare a mezzo e-mail (utilizzando l'indirizzo istituzionale- @studenti.unipd.it) la richesta di ricevimento al fine di fissare l'appuntamento.
Teachings
- PHARMACEUTICAL LEGISLATION AND PHARMACOECONOMICS, AA 2023 (MEP8082739)
- PHARMACEUTICAL LEGISLATION AND PHARMACOECONOMICS, AA 2023 (MEP8082739)
- PHARMACEUTICAL TECHNOLOGY AND COMPOUNDING, AA 2023 (MEP8082712)
- PHARMACEUTICAL TECHNOLOGY AND COMPOUNDING, AA 2023 (MEP8082712)
- DEVELOPMENT AND LAW OF BOTANICALS (PART B), AA 2022 (MEP4068013)
- PHARMACEUTICAL LEGISLATION AND PHARMACOECONOMICS, AA 2022 (MEP8082739)
- PHARMACEUTICAL TECHNOLOGY AND COMPOUNDING, AA 2022 (MEP8082712)
- PHARMACEUTICAL LEGISLATION AND PHARMACOECONOMICS, AA 2021 (MEP8082739)
- PHARMACEUTICAL TECHNOLOGY AND COMPOUNDING, AA 2021 (MEP8082712)
- DEVELOPMENT AND LAW OF BOTANICALS (PART B), AA 2020 (MEP4068013)
- BOTANICALS FOR HEALTHY AND COSMETIC USE (I.C.), AA 2020 (MEP4068012)
- PHARMACEUTICAL TECHNOLOGY AND LEGISLATION, AA 2020 (FAO2043797)
- DEVELOPMENT AND LAW OF BOTANICALS (PART B), AA 2019 (MEP4068013)
- BOTANICALS FOR HEALTHY AND COSMETIC USE (I.C.), AA 2019 (MEP4068012)
- PHARMACEUTICAL TECHNOLOGY AND LEGISLATION, AA 2019 (FAO2043797)
- DEVELOPMENT AND LAW OF BOTANICALS (PART B), AA 2018 (MEP4068013)
- BOTANICALS FOR HEALTHY AND COSMETIC USE (I.C.), AA 2018 (MEP4068012)
- COMPUTERIZED MANAGEMENT OF PHARMACY, AA 2018 (FAL1002934)
- PHARMACEUTICAL TECHNOLOGY AND LEGISLATION, AA 2018 (FAO2043797)
- PHARMACEUTICAL TECHNOLOGY, AA 2018 (FAO2043794)
- DEVELOPMENT AND LAW OF BOTANICALS (PART B), AA 2017 (MEP4068013)
- BOTANICALS FOR HEALTHY AND COSMETIC USE (I.C.), AA 2017 (MEP4068012)
- COMPUTERIZED MANAGEMENT OF PHARMACY, AA 2017 (FAL1002934)
- PHARMACEUTICAL TECHNOLOGY AND LEGISLATION, AA 2017 (FAO2043797)
- PHARMACEUTICAL TECHNOLOGY, AA 2017 (FAO2043794)
- DEVELOPMENT AND LAW OF BOTANICALS (PART B), AA 2016 (MEP4068013)
- BOTANICALS FOR HEALTHY AND COSMETIC USE (I.C.), AA 2016 (MEP4068012)
- COMPUTERIZED MANAGEMENT OF PHARMACY, AA 2016 (FAL1002934)
- PHARMACEUTICAL TECHNOLOGY AND LEGISLATION, AA 2016 (FAO2043797)
- PHARMACEUTICAL TECHNOLOGY, AA 2016 (FAO2043794)
- DEVELOPMENT AND LAW OF BOTANICALS (PART B), AA 2015 (MEP3052209)
- BOTANICALS FOR HEALTHY AND COSMETIC USE (I.C.), AA 2015 (MEP3052207)
- COMPUTERIZED MANAGEMENT OF PHARMACY, AA 2015 (FAL1002934)
- PHARMACEUTICAL TECHNOLOGY AND LEGISLATION, AA 2015 (FAO2043797)
- PHARMACEUTICAL TECHNOLOGY, AA 2015 (FAO2043794)
- DEVELOPMENT AND LAW OF BOTANICALS (PART B), AA 2014 (MEP3052209)
- COMPUTERIZED MANAGEMENT OF PHARMACY, AA 2014 (FAL1002934)
- PHARMACEUTICAL TECHNOLOGY AND LEGISLATION, AA 2014 (FAO2043797)
- PHARMACEUTICAL TECHNOLOGY, AA 2014 (FAO2043794)
- DEVELOPMENT AND LAW OF BOTANICALS (PART B), AA 2013 (MEP3052209)
- BOTANICALS FOR HEALTHY AND COSMETIC USE (I.C.), AA 2013 (MEP3052207)
- CONTRACT MANUFACTORING, AA 2012 (FAL1000590)
- CONTRACT MANUFACTORING, AA 2011 (FAL1000590)
Research Area
Research activity is focused in the delivery of drugs from pharmaceutical forms and the influence of physical-chemical parameters on the release and bioavailability of the therapeutic agent. He studies pharmaceutical forms of dermatological application, suppositories, tablets, parenteral preparations and solid polymeric matrices. More recently, he is interested in radiopharmaceutical preparations and in vitro and in vivo immunodiagnostics and drug delivery.
The research concerns the use of specific auxiliary agents for the modulation of the availability of drugs from suppositories; the study of the influence of manufacturing methods on the availability of ointment drugs; the development of a method for the in vivo evaluation of skin absorption and a method for the assessment of the compatibility of plastic materials used in the construction of containers with the components of injections. Furthermore, it deals with studies in the field of clinical galenic; studies on the quality assessment of medical devices. In the field of radiopharmaceuticals, he works to a new ISOL-production method of high specific activity beta-emitting radionuclides as radiopharmaceutical precursors.
He also develops analysis, critical review and opinions on the pharmaceutical doctrine.